Literature DB >> 15934889

Mirtazapine: a review of its clinical efficacy and tolerability.

Armin Szegedi1, Natascha Schwertfeger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15934889     DOI： 10.1517/14656566.6.4.631

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  13 in total

1.  Repeated administration of mirtazapine attenuates oxaliplatin-induced mechanical allodynia and spinal NR2B up-regulation in rats.

Authors:  Xiaoyu Liu; Guangfen Zhang; Lin Dong; Xingming Wang; Heliang Sun; Jinchun Shen; Weiyan Li; Jianguo Xu
Journal:  Neurochem Res       Date:  2013-07-09       Impact factor: 3.996

2.  Neuroimaging of mirtazapine enantiomers in humans.

Authors:  Donald F Smith; Søren B Hansen; Steen Jakobsen; Dirk Bender; Hélène Audrain; Mahmoud Ashkanian; Bo S Stork; Luciano Minuzzi; Håkan Hall; Raben Rosenberg
Journal:  Psychopharmacology (Berl)       Date:  2008-06-20       Impact factor: 4.530

3.  Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.

Authors:  Eylem Sahin Cankurtaran; Elvan Ozalp; Haldun Soygur; Derya Iren Akbiyik; Levent Turhan; Necati Alkis
Journal:  Support Care Cancer       Date:  2008-02-26       Impact factor: 3.603

4.  Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization.

Authors:  Anne Dekeyne; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

5.  [11C]Mirtazapine binding in depressed antidepressant nonresponders studied by PET neuroimaging.

Authors:  Donald F Smith; Bo S Stork; Gregers Wegener; Mahmoud Ashkanian; Steen Jakobsen; Dirk Bender; Hélène Audrain; Karina H Vase; Søren B Hansen; Poul Videbech; Raben Rosenberg
Journal:  Psychopharmacology (Berl)       Date:  2009-06-18       Impact factor: 4.530

6.  Receptor occupancy of mirtazapine determined by PET in healthy volunteers.

Authors:  Donald F Smith; Bo S Stork; Gregers Wegener; Steen Jakobsen; Dirk Bender; Hélène Audrain; Svend B Jensen; Søren B Hansen; Anders Rodell; Raben Rosenberg
Journal:  Psychopharmacology (Berl)       Date:  2007-07-25       Impact factor: 4.530

Review 7.  Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.

Authors:  Mark J Millan
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

8.  Mirtazapine provokes periodic leg movements during sleep in young healthy men.

Authors:  Stephany Fulda; Stefan Kloiber; Tatjana Dose; Susanne Lucae; Florian Holsboer; Ludwig Schaaf; Johannes Hennings
Journal:  Sleep       Date:  2013-05-01       Impact factor: 5.849

9.  JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.

Authors:  Colleen L Mayberry; Christian D S Nelson; Melissa S Maginnis
Journal:  Curr Clin Microbiol Rep       Date:  2017-08-01

10.  Platelet-derived serotonin links vascular disease and tissue fibrosis.

Authors:  Clara Dees; Alfiya Akhmetshina; Pawel Zerr; Nicole Reich; Katrin Palumbo; Angelika Horn; Astrid Jüngel; Christian Beyer; Gerhard Krönke; Jochen Zwerina; Rudolf Reiter; Natalia Alenina; Luc Maroteaux; Steffen Gay; Georg Schett; Oliver Distler; Jörg H W Distler
Journal:  J Exp Med       Date:  2011-04-25       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.